WesBanco Bank’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

WesBanco Bank’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,400	Closed	-$621K	–	559
2014 Q4	$621K	Buy	5,400 +323	+6%	+$39.1K	0.03%	301
2014 Q3	$793K	Buy	5,077 +177	+4%	+$25.7K	0.04%	274
2014 Q2	$604K	Hold	4,900	–	–	0.03%	310
2014 Q1	$508K	Sell	4,900 -600	-11%	-$61.4K	0.03%	335
2013 Q4	$495K	Buy	5,500 +100	+2%	+$7.98K	0.03%	332
2013 Q3	$361K	Buy	5,400 +300	+6%	+$20.7K	0.02%	386
2013 Q2	$337K	Buy	+5,100	New	+$292K	0.02%	387

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WesBanco Bank's SLXP Position: Q1 2015 in Review

WesBanco Bank sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 5,400 shares — an estimated $621K sold.

WesBanco Bank first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $793K in Q3 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

WesBanco Bank reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
WesBanco Bank sold 5,400 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $621K.
WesBanco Bank first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
WesBanco Bank's SALIX PHARMACEUTICALS LTD DEL position peaked at $793K in Q3 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on WesBanco Bank's 13F filing for Q1 2015, filed 4 May 2015.